Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054. Issue 1 (18th January 2022)

Record Type:: Journal Article
Title:: Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054. Issue 1 (18th January 2022)
Main Title:: Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054
Authors:: Eggermont, Alexander
Kicinski, Michal
Suciu, Stefan
Abstract:
Is Part Of:: Journal for immunotherapy of cancer. Volume 10:Issue 1(2022)
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 10:Issue 1(2022)
Issue Display:: Volume 10, Issue 1 (2022)
Year:: 2022
Volume:: 10
Issue:: 1
Issue Sort Value:: 2022-0010-0001-0000
Page Start:
Page End:
Publication Date:: 2022-01-18
Subjects:: immunotherapy -- melanoma -- adjuvants -- immunologic -- autoimmunity
Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105
Journal URLs:: http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗
DOI:: 10.1136/jitc-2021-004272 ↗
Languages:: English
ISSNs:: 2051-1426
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 23073.xml